Income Statement Inter Pharma

Stocks

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E. Other stock markets 2026-07-08			5-day change	1st Jan Change
4.820 ^THB	+6.64%		+8.07%	+4.78%

05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI

23d6e3abdc77f9a5d5751fc36.2JALkytLGYOcTZrjytCu7uh_ixedKp_2nrREnAIAJd4.s6ZgpVkjQMnVHfW0j6mfq64Pv1uwesiH_fYFzTVMZrru80-qQgV26-oiww

Published financial data: INTER PHARMA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	909M	1.52B	1.78B	1.9B	2.19B
Other Revenues, Total	12.35M	11.12M	17.54M	14.62M	20.57M
Total Revenues	921M	1.53B	1.8B	1.91B	2.21B
Cost of Goods Sold, Total	508M	905M	1.12B	1.19B	1.29B
Gross Profit	413M	630M	677M	725M	921M
Selling General & Admin Expenses, Total	267M	458M	568M	649M	729M
Other Operating Expenses, Total	267M	458M	568M	649M	729M
Operating Income	146M	172M	109M	75.53M	192M
Interest Expense, Total	-8.01M	-23.34M	-25.76M	-19.85M	-19.58M
Net Interest Expenses	-8.01M	-23.34M	-25.76M	-19.85M	-19.58M
Income (Loss) On Equity Invest.	-78.63K	-768K	-2.27M	-1.59M	-1.23M
EBT, Excl. Unusual Items	138M	148M	81.37M	54.1M	171M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	138M	148M	81.37M	54.1M	171M
Income Tax Expense	27.2M	19.59M	22.47M	16.42M	35.1M
Earnings From Continuing Operations	110M	128M	58.9M	37.68M	136M
Net Income to Company	110M	128M	58.9M	37.68M	136M
Minority Interest	-5.27M	-8.77M	-8.11M	-399K	-13.69M
Net Income - (IS)	105M	119M	50.79M	37.28M	122M
Net Income to Common Incl Extra Items	105M	119M	50.79M	37.28M	122M
Net Income to Common Excl. Extra Items	105M	119M	50.79M	37.28M	122M
Per Share Items
Net EPS - Basic	0.22	0.22	0.08	0.06	0.2
Basic EPS - Continuing Operations	0.22	0.22	0.08	0.06	0.2
Basic Weighted Average Shares Outstanding	475M	532M	605M	605M	605M
Net EPS - Diluted	0.22	0.22	0.08	0.06	0.2
Diluted EPS - Continuing Operations	0.22	0.22	0.08	0.06	0.2
Diluted Weighted Average Shares Outstanding	475M	532M	605M	605M	605M
Normalized Basic EPS	0.17	0.16	0.07	0.06	0.15
Normalized Diluted EPS	0.17	0.16	0.07	0.06	0.15
Dividend Per Share	-	0.11	0.02	-	0.07
Payout Ratio	4.59	-	131.92	34.78	-
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	171M	209M	168M	138M	272M
EBITA	151M	177M	124M	87.1M	207M
EBIT	146M	172M	109M	75.53M	192M
EBITDAR	-	210M	184M	149M	307M
Total Revenues (As Reported)	921M	1.53B	1.8B	1.91B	2.21B
Effective Tax Rate - (Ratio)	19.75	13.27	27.61	30.35	20.5
Current Domestic Taxes	36.76M	30.96M	25.5M	21.77M	42.29M
Total Current Taxes	36.76M	30.96M	25.5M	21.77M	42.29M
Deferred Domestic Taxes	-9.56M	-11.37M	-3.03M	-5.35M	-7.19M
Total Deferred Taxes	-9.56M	-11.37M	-3.03M	-5.35M	-7.19M
Normalized Net Income	80.78M	83.48M	42.74M	33.41M	93.29M
Interest on Long-Term Debt	-	4.49M	5.23M	5.54M	5.74M
Non-Cash Pension Expense	203K	572K	839K	1.03M	1.42M
Supplemental Operating Expense Items
Advertising Expense	41.13M	31.91M	70.61M	93.14M	31.27M
Selling and Marketing Expenses	165M	279M	377M	443M	503M
General and Administrative Expenses	102M	179M	191M	206M	226M
Net Rental Expense, Total	-	1.34M	16.64M	10.54M	34.14M
Imputed Operating Lease Interest Expense	-	557K	7.3M	4.21M	13.44M
Imputed Operating Lease Depreciation	-	778K	9.34M	6.33M	20.7M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	174M	776M	412M	185M	281M
Short Term Investments	800K	828K	855K	928K	1.01M
Total Cash And Short Term Investments	175M	777M	413M	186M	282M
Accounts Receivable, Total	258M	340M	337M	376M	375M
Other Receivables	35.04M	51.89M	87.74M	71.37M	81.82M
Notes Receivable	60K	5K	-	-	-
Total Receivables	293M	392M	425M	447M	457M
Inventory	192M	333M	352M	339M	359M
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	6.75M	12.78M	12.72M	9.35M	8.8M
Total Current Assets	667M	1.52B	1.2B	982M	1.11B
Gross Property Plant And Equipment	511M	1.08B	1.27B	1.53B	1.64B
Accumulated Depreciation	-53.96M	-296M	-339M	-381M	-427M
Net Property Plant And Equipment	457M	788M	929M	1.15B	1.21B
Long-term Investments	10.12M	9.35M	43.37M	41.78M	36.29M
Goodwill	22.16M	521M	478M	478M	563M
Other Intangibles, Total	55.1M	153M	197M	204M	220M
Accounts Receivable Long-Term	-	-	-	-	2.06M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	8.98M	9.81M	15.91M	20.17M	20.94M
Other Long-Term Assets, Total	107M	29.52M	85.75M	144M	80.47M
Total Assets	1.33B	3.03B	2.95B	3.02B	3.24B
Liabilities
Accounts Payable, Total	69.66M	194M	201M	185M	213M
Accrued Expenses, Total	15.92M	34.5M	47.06M	46.03M	60.52M
Short-term Borrowings	131M	48.73M	46.34M	79.91M	119M
Current Portion of Long-Term Debt	35.62M	72.51M	54.43M	55.2M	62.42M
Current Portion of Leases	568K	30.46M	38.89M	26.64M	32.83M
Current Income Taxes Payable	14.8M	25.18M	4.11M	11.84M	24.53M
Unearned Revenue Current, Total	-	-	-	4.59M	5.33M
Other Current Liabilities	68.06M	92.79M	87.39M	117M	120M
Total Current Liabilities	336M	498M	479M	526M	638M
Long-Term Debt	187M	320M	205M	167M	124M
Long-Term Leases	1.9M	67.69M	54.83M	65.5M	61.91M
Pension & Other Post Retirement Benefits	15.41M	31.14M	32.75M	40.88M	48.85M
Deferred Tax Liability Non Current	3.53M	33.71M	59.21M	58.22M	54.61M
Other Non Current Liabilities	-	2.14M	3.66M	8.32M	11.99M
Total Liabilities	544M	952M	835M	866M	940M
Common Stock, Total	149M	186M	186M	303M	303M
Additional Paid In Capital	492M	1.5B	1.5B	1.5B	1.5B
Retained Earnings	117M	239M	225M	132M	255M
Comprehensive Income and Other	3.7M	3.7M	3.7M	3.7M	3.7M
Total Common Equity	762M	1.93B	1.91B	1.94B	2.06B
Minority Interest	21.86M	147M	205M	217M	240M
Total Equity	784M	2.07B	2.12B	2.15B	2.3B
Total Liabilities And Equity	1.33B	3.03B	2.95B	3.02B	3.24B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	484M	605M	605M	605M	605M
ECS Total Common Shares Outstanding	484M	605M	605M	605M	605M
Book Value / Share	1.57	3.18	3.16	3.2	3.4
Tangible Book Value	684M	1.25B	1.24B	1.25B	1.28B
Tangible Book Value Per Share	1.41	2.07	2.05	2.07	2.11
Total Debt	356M	539M	400M	394M	401M
Net Debt	182M	-238M	-13.3M	209M	119M
Debt Equivalent of Unfunded Proj. Benefit Obligation	15.69M	31.38M	35.54M	42.19M	49.68M
Debt Equivalent Oper. Leases	-	10.68M	133M	84.32M	273M
Minority Interest, Total (Incl. Fin. Div)	21.86M	147M	205M	217M	240M
Equity Method Investments, Total	10.12M	9.35M	7.08M	5.49M	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	64.91M	93.51M	81.43M	66.81M	69.37M
Inventories - Work In Process, Total	5.32M	5.24M	2.13M	3.09M	2.3M
Inventories - Finished Goods, Total	120M	235M	269M	272M	290M
Inventories - Others	-	-	-	2.31M	1.83M
Land - (BS)	183M	328M	328M	334M	334M
Buildings, Total	177M	336M	430M	535M	630M
Machinery, Total	148M	284M	347M	380M	398M
Full Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	7.82M	20.56M	24.45M	32.5M	38.48M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	105M	119M	50.79M	37.28M	122M
Depreciation & Amortization - CF	20.58M	58M	83.07M	96.65M	97.55M
Amortization of Goodwill and Intangible Assets - (CF)	5.09M	5.56M	14.11M	11.57M	15.11M
Depreciation & Amortization, Total	25.67M	63.56M	97.18M	108M	113M
Amortization of Deferred Charges, Total - (CF)	934K	1.28M	1.07M	3.04M	4.08M
(Gain) Loss From Sale Of Asset	3.6M	834K	471K	1.08M	1.07M
(Gain) Loss on Sale of Investments - (CF)	1.8M	5.17M	3.89M	8.14M	8.96M
Asset Writedown & Restructuring Costs	-	-	3.05M	129K	820K
(Income) Loss On Equity Investments - (CF)	78.63K	768K	2.27M	1.59M	1.23M
Stock-Based Compensation (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	-	-2.77M
Other Operating Activities, Total	16.21M	32.19M	22.44M	32.33M	56.6M
Change In Accounts Receivable	-138M	-43.02M	-43.82M	-15.63M	-15.63M
Change In Inventories	-85.31M	-60.61M	-24.4M	20.79M	-31.7M
Change In Accounts Payable	35.21M	26.32M	10.15M	-15.88M	53.24M
Change in Other Net Operating Assets	-6.62M	-2.63M	-1.68M	-3.25M	-3.05M
Cash from Operations	-41.57M	143M	121M	178M	308M
Capital Expenditure	-224M	-27.37M	-106M	-237M	-141M
Sale of Property, Plant, and Equipment	2.8M	247K	48K	1.54M	2.39M
Cash Acquisitions	-107M	-538M	-	-95.18M	-1.9M
Sale (Purchase) of Intangible assets	-13.69M	-22.6M	-37.63M	-24.03M	-23.13M
Investment in Marketable and Equity Securities, Total	-10.23M	-24.61K	-36.32M	-72.29K	-80.56K
Other Investing Activities, Total	59.39K	63.13K	-52.4M	45.16M	-7.21M
Cash from Investing	-352M	-588M	-233M	-310M	-170M
Short Term Debt Issued, Total	120M	20M	45M	99.18M	41.22M
Long-Term Debt Issued, Total	139M	200M	6M	-	29.8M
Total Debt Issued	259M	220M	51M	99.18M	71.02M
Short Term Debt Repaid, Total	-	-112M	-47.6M	-65.4M	-1.8M
Long-Term Debt Repaid, Total	-23.19M	-79.68M	-171M	-96.64M	-96.17M
Total Debt Repaid	-23.19M	-192M	-219M	-162M	-97.97M
Issuance of Common Stock	192M	1.04B	-	-	2.17K
Common Dividends Paid	-4.83M	-	-67M	-12.97M	-
Common & Preferred Stock Dividends Paid	-4.83M	-	-67M	-12.97M	-
Other Financing Activities, Total	-8.28M	-23.55M	-17.83M	-19.62M	-14.31M
Cash from Financing	415M	1.05B	-253M	-95.45M	-41.26M
Foreign Exchange Rate Adjustments	-14.72K	-255K	171K	-169K	-98.56K
Net Change in Cash	21.54M	603M	-364M	-228M	96.04M
Supplemental Items
Cash Interest Paid	7.67M	23.05M	24.03M	19.62M	18.84M
Cash Income Tax Paid (Refund)	31.08M	31.56M	46.73M	16.48M	28.78M
Levered Free Cash Flow	-318M	39.41M	-52.37M	-96.62M	91.71M
Unlevered Free Cash Flow	-313M	54M	-36.27M	-84.22M	104M
Change In Net Working Capital	192M	68.19M	58.81M	-18.78M	-30.91M
Net Debt Issued / Repaid	236M	28.26M	-168M	-62.86M	-26.95M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.75	4.93	2.26	1.58	3.83
Return on Total Capital	10.43	5.72	2.64	1.86	4.57
Return On Equity %	17.4	8.96	2.78	1.76	6.11
Return on Common Equity	17.09	8.87	2.65	1.94	6.13
Margin Analysis
Gross Profit Margin %	44.86	41.03	37.64	37.9	41.59
SG&A Margin	29.03	29.84	31.55	33.95	32.92
EBITDA Margin %	18.62	13.6	9.32	7.24	12.31
EBITA Margin %	16.38	11.55	6.87	4.56	9.35
EBIT Margin %	15.83	11.19	6.08	3.95	8.67
Income From Continuing Operations Margin %	12	8.34	3.27	1.97	6.15
Net Income Margin %	11.42	7.77	2.82	1.95	5.53
Net Avail. For Common Margin %	11.42	7.77	2.82	1.95	5.53
Normalized Net Income Margin	8.77	5.44	2.38	1.75	4.21
Levered Free Cash Flow Margin	-34.49	2.57	-2.91	-5.05	4.14
Unlevered Free Cash Flow Margin	-33.94	3.52	-2.02	-4.4	4.69
Asset Turnover
Asset Turnover	0.88	0.71	0.6	0.64	0.71
Fixed Assets Turnover	2.58	2.47	1.99	1.84	1.88
Receivables Turnover (Average Receivables)	4.75	5.09	5.26	5.32	5.84
Inventory Turnover (Average Inventory)	3.39	3.45	3.28	3.43	3.7
Short Term Liquidity
Current Ratio	1.99	3.04	2.51	1.87	1.73
Quick Ratio	1.39	2.35	1.75	1.2	1.16
Operating Cash Flow to Current Liabilities	-0.12	0.29	0.25	0.34	0.48
Days Sales Outstanding (Average Receivables)	76.82	71.69	69.43	68.81	62.48
Days Outstanding Inventory (Average Inventory)	107.68	105.88	111.41	106.55	98.53
Average Days Payable Outstanding	39.49	45.97	63.09	59.98	55.28
Cash Conversion Cycle (Average Days)	145.01	131.6	117.75	115.38	105.73
Long Term Solvency
Total Debt/Equity	45.46	25.99	18.89	18.31	17.44
Total Debt / Total Capital	31.25	20.63	15.89	15.48	14.85
LT Debt/Equity	24.12	18.68	12.29	10.8	8.11
Long-Term Debt / Total Capital	16.58	14.82	10.34	9.13	6.9
Total Liabilities / Total Assets	40.96	31.47	28.27	28.68	29.02
EBIT / Interest Expense	18.2	7.36	4.25	3.81	9.81
EBITDA / Interest Expense	21.4	10.08	8.02	9.26	15.56
(EBITDA - Capex) / Interest Expense	-6.58	8.91	3.89	-2.7	8.38
Total Debt / EBITDA	2.08	2.29	1.94	2.15	1.32
Net Debt / EBITDA	1.06	-1.01	-0.06	1.14	0.39
Total Debt / (EBITDA - Capex)	-6.76	2.59	3.99	-7.35	2.44
Net Debt / (EBITDA - Capex)	-3.44	-1.15	-0.13	-3.89	0.73
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	106.06	66.61	17.23	6.29	15.8
Gross Profit, 1 Yr. Growth %	56.39	52.39	7.62	7.04	27.11
EBITDA, 1 Yr. Growth %	108.72	22.15	-19.67	-17.48	96.69
EBITA, 1 Yr. Growth %	95.61	17.5	-29.97	-29.48	141.39
EBIT, 1 Yr. Growth %	89.44	17.79	-35.95	-30.96	158.66
Earnings From Cont. Operations, 1 Yr. Growth %	86.45	15.86	-53.72	-36.03	271.49
Net Income, 1 Yr. Growth %	100.27	13.33	-57.28	-26.6	233.93
Normalized Net Income, 1 Yr. Growth %	99.17	3.34	-48.67	-21.84	182.61
Diluted EPS Before Extra, 1 Yr. Growth %	98.19	1.21	-62.45	-26.6	233.93
Accounts Receivable, 1 Yr. Growth %	107.52	31.85	-0.88	11.49	-0.32
Inventory, 1 Yr. Growth %	78.35	73.43	5.66	-3.51	5.68
Net Property, Plant and Equip., 1 Yr. Growth %	79.07	72.2	5.51	23.76	5.19
Total Assets, 1 Yr. Growth %	75.46	128.01	-4.46	2.31	7
Tangible Book Value, 1 Yr. Growth %	71.48	82.96	-3.33	1.33	10.42
Common Equity, 1 Yr. Growth %	62.1	152.95	-0.68	1.23	6.35
Cash From Operations, 1 Yr. Growth %	371.52	-444.19	-15.15	46.46	73.12
Capital Expenditures, 1 Yr. Growth %	1.7K	-87.79	288.95	123.02	-40.8
Levered Free Cash Flow, 1 Yr. Growth %	-1.5K	-112.41	-231.76	84.49	-195.41
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.43K	-117.27	-166.76	132.17	-224.16
Dividend Per Share, 1 Yr. Growth %	-	-	-80.69	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	56.53	85.29	39.75	11.63	10.94
Gross Profit, 2 Yr. CAGR %	37.51	54.38	28.01	7.33	16.62
EBITDA, 2 Yr. CAGR %	64.16	59.4	-0.94	-18.58	27.49
EBITA, 2 Yr. CAGR %	56.08	51.61	-9.52	-29.73	29.48
EBIT, 2 Yr. CAGR %	53.62	49.38	-13.37	-33.5	32.47
Earnings From Cont. Operations, 2 Yr. CAGR %	53.11	46.98	-26.98	-45.59	51.99
Net Income, 2 Yr. CAGR %	55.57	50.66	-30.52	-44	55.23
Normalized Net Income, 2 Yr. CAGR %	53.16	43.47	-27.26	-36.66	47.73
Diluted EPS Before Extra, 2 Yr. CAGR %	34.75	41.63	-38.45	-47.5	55.23
Accounts Receivable, 2 Yr. CAGR %	58.55	65.41	14.32	5.12	5.42
Inventory, 2 Yr. CAGR %	93.22	75.88	35.37	0.97	0.98
Net Property, Plant and Equip., 2 Yr. CAGR %	587.84	75.6	42.55	14.27	14.12
Total Assets, 2 Yr. CAGR %	58.85	100.02	49.16	-1.14	4.74
Tangible Book Value, 2 Yr. CAGR %	22.72	77.13	34.49	-1.02	1.53
Common Equity, 2 Yr. CAGR %	29.28	102.49	58.49	0.27	3.74
Cash From Operations, 2 Yr. CAGR %	187.37	302.85	70.9	11.48	59.24
Capital Expenditures, 2 Yr. CAGR %	1.8K	48.25	-31.08	194.52	14.9
Levered Free Cash Flow, 2 Yr. CAGR %	482.55	31.6	-59.39	55.91	32.33
Unlevered Free Cash Flow, 2 Yr. CAGR %	489.66	51.69	-65.94	24.5	69.29
Dividend Per Share, 2 Yr. CAGR %	-	227.98	-	-	84.69
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	42.6	59.82	59.07	27.57	13
Gross Profit, 3 Yr. CAGR %	28.98	42.3	36.85	20.6	13.54
EBITDA, 3 Yr. CAGR %	58.92	48.58	26.85	-6.79	9.3
EBITA, 3 Yr. CAGR %	54.43	41.99	17	-16.73	5.5
EBIT, 3 Yr. CAGR %	52.67	40.61	12.45	-19.68	3.97
Earnings From Cont. Operations, 3 Yr. CAGR %	56.08	39.52	-0.2	-30.13	2.25
Net Income, 3 Yr. CAGR %	52.48	39.98	-1.12	-29.24	0.97
Normalized Net Income, 3 Yr. CAGR %	46.31	34.34	1.76	-25.49	3.86
Diluted EPS Before Extra, 3 Yr. CAGR %	23.75	22.49	-9.11	-34.73	-3.28
Accounts Receivable, 3 Yr. CAGR %	45.84	49.1	39.45	13.37	3.28
Inventory, 3 Yr. CAGR %	50.83	86.38	48.4	20.92	2.52
Net Property, Plant and Equip., 3 Yr. CAGR %	249.19	333.52	53.81	35.99	11.17
Total Assets, 3 Yr. CAGR %	89.35	79.19	57.45	31.54	1.58
Tangible Book Value, 3 Yr. CAGR %	89.57	40.19	45.84	22.38	-0.12
Common Equity, 3 Yr. CAGR %	96.39	61.7	59.69	36.49	2.25
Cash From Operations, 3 Yr. CAGR %	88.69	205.18	139.69	62.33	29.1
Capital Expenditures, 3 Yr. CAGR %	189.71	252.87	104.47	1.94	72.52
Levered Free Cash Flow, 3 Yr. CAGR %	147.82	61.48	32.03	-32.75	32.14
Unlevered Free Cash Flow, 3 Yr. CAGR %	146.62	81.77	15.62	-35.42	24.14
Dividend Per Share, 3 Yr. CAGR %	-	10.87	27.6	-	-12.98
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	48.99	43.98	41.46	38.45	37.72
Gross Profit, 5 Yr. CAGR %	36.81	33.46	28.59	27.1	28.37
EBITDA, 5 Yr. CAGR %	42.85	47.86	31.45	16.81	27.1
EBITA, 5 Yr. CAGR %	40.68	43.99	24.7	7.06	21.84
EBIT, 5 Yr. CAGR %	39.72	43.08	21.71	4.1	20.06
Earnings From Cont. Operations, 5 Yr. CAGR %	47.86	51.73	15.18	-4.38	18.09
Net Income, 5 Yr. CAGR %	46.43	49.97	11.34	-3.03	18.43
Normalized Net Income, 5 Yr. CAGR %	36.6	36.66	10.63	-0.6	18.13
Diluted EPS Before Extra, 5 Yr. CAGR %	-20.26	15.97	-6.41	-12.77	12.59
Accounts Receivable, 5 Yr. CAGR %	79.77	57.44	32.3	29.65	24.69
Inventory, 5 Yr. CAGR %	58.17	88.59	44.44	45.86	27.22
Net Property, Plant and Equip., 5 Yr. CAGR %	150.06	159.31	144.02	160.07	36.5
Total Assets, 5 Yr. CAGR %	75.43	95.99	72.12	41.85	33.76
Tangible Book Value, 5 Yr. CAGR %	79.36	76.51	65.25	22.52	26.17
Common Equity, 5 Yr. CAGR %	83.14	92.3	80.25	33.56	34.38
Cash From Operations, 5 Yr. CAGR %	10.54	65.7	81.36	103.99	103.52
Capital Expenditures, 5 Yr. CAGR %	182.22	46.01	63.12	228.26	62.37
Levered Free Cash Flow, 5 Yr. CAGR %	-	3.51	20.2	59.5	32.15
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	10.22	11.72	56.43	34.67
Dividend Per Share, 5 Yr. CAGR %	-	-6.35	-11.36	-	47.94